Health & Life Co., Ltd. (TPEX:1781)
12.40
-0.20 (-1.59%)
Feb 11, 2026, 1:30 PM CST
Health & Life Revenue
Health & Life had revenue of 89.56M TWD in the quarter ending September 30, 2025, a decrease of -60.49%. This brings the company's revenue in the last twelve months to 441.84M, down -33.17% year-over-year. In the year 2024, Health & Life had annual revenue of 706.39M with 17.50% growth.
Revenue (ttm)
441.84M
Revenue Growth
-33.17%
P/S Ratio
1.33
Revenue / Employee
n/a
Employees
n/a
Market Cap
587.85M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 706.39M | 105.22M | 17.50% |
| Dec 31, 2023 | 601.17M | -196.37M | -24.62% |
| Dec 31, 2022 | 797.54M | -14.34M | -1.77% |
| Dec 31, 2021 | 811.88M | 37.72M | 4.87% |
| Dec 31, 2020 | 774.16M | 352.99M | 83.81% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Rossmax International | 3.82B |
| AViTA | 896.85M |
| Bioptik Technology Incorporation | 829.18M |
| EPS Bio Technology | 497.19M |
| Radiant Innovation | 413.06M |
| Wiltrom | 338.37M |
| S&S Healthcare Holding | 205.64M |
| Taiwan Advanced Nanotech | 172.11M |